Details
Stereochemistry | MIXED |
Molecular Formula | C16H22O3 |
Molecular Weight | 262.3441 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 0 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1CC(CC(C)(C)C1)OC(=O)C2=CC=CC=C2O
InChI
InChIKey=WSSJONWNBBTCMG-UHFFFAOYSA-N
InChI=1S/C16H22O3/c1-11-8-12(10-16(2,3)9-11)19-15(18)13-6-4-5-7-14(13)17/h4-7,11-12,17H,8-10H2,1-3H3
DescriptionCurator's Comment: http://www.fda.gov/downloads/ForConsumers/ConsumerUpdates/UCM258718.pdf
Curator's Comment: http://www.fda.gov/downloads/ForConsumers/ConsumerUpdates/UCM258718.pdf
Homosalate is used as a broad-band UV filter in concentrations of up to 10% in the EU or 15% depending upon where the product is used (e.g. in the USA) in sunscreen products alone or in combination with other UV absorbers to protect the skin against harmful effects of the UV radiation.
Approval Year
Cmax
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
7.6 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31961417/ |
2 mg/cm² single, topical dose: 2 mg/cm² route of administration: Topical experiment type: SINGLE co-administered: |
HOMOSALATE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
23.1 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31961417/ |
2 mg/cm² 4 times / day multiple, topical dose: 2 mg/cm² route of administration: Topical experiment type: MULTIPLE co-administered: |
HOMOSALATE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
4.6 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31961417/ |
2 mg/cm² single, topical dose: 2 mg/cm² route of administration: Topical experiment type: SINGLE co-administered: |
HOMOSALATE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
17.9 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31961417/ |
2 mg/cm² 4 times / day multiple, topical dose: 2 mg/cm² route of administration: Topical experiment type: MULTIPLE co-administered: |
HOMOSALATE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
3.8 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31961417/ |
2 mg/cm² single, topical dose: 2 mg/cm² route of administration: Topical experiment type: SINGLE co-administered: |
HOMOSALATE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
14.3 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31961417/ |
2 mg/cm² 4 times / day multiple, topical dose: 2 mg/cm² route of administration: Topical experiment type: MULTIPLE co-administered: |
HOMOSALATE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
AUC
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
104 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31961417/ |
2 mg/cm² single, topical dose: 2 mg/cm² route of administration: Topical experiment type: SINGLE co-administered: |
HOMOSALATE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
350.8 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31961417/ |
2 mg/cm² 4 times / day multiple, topical dose: 2 mg/cm² route of administration: Topical experiment type: MULTIPLE co-administered: |
HOMOSALATE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
62.3 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31961417/ |
2 mg/cm² single, topical dose: 2 mg/cm² route of administration: Topical experiment type: SINGLE co-administered: |
HOMOSALATE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
267.4 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31961417/ |
2 mg/cm² 4 times / day multiple, topical dose: 2 mg/cm² route of administration: Topical experiment type: MULTIPLE co-administered: |
HOMOSALATE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
47.6 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31961417/ |
2 mg/cm² single, topical dose: 2 mg/cm² route of administration: Topical experiment type: SINGLE co-administered: |
HOMOSALATE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
199 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31961417/ |
2 mg/cm² 4 times / day multiple, topical dose: 2 mg/cm² route of administration: Topical experiment type: MULTIPLE co-administered: |
HOMOSALATE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
T1/2
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
67.9 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31961417/ |
2 mg/cm² single, topical dose: 2 mg/cm² route of administration: Topical experiment type: SINGLE co-administered: |
HOMOSALATE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
78.4 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31961417/ |
2 mg/cm² single, topical dose: 2 mg/cm² route of administration: Topical experiment type: SINGLE co-administered: |
HOMOSALATE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
46.9 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31961417/ |
2 mg/cm² single, topical dose: 2 mg/cm² route of administration: Topical experiment type: SINGLE co-administered: |
HOMOSALATE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
Doses
Dose | Population | Adverse events |
---|---|---|
3 % 1 times / 2 hours multiple, topical Recommended Dose: 3 %, 1 times / 2 hours Route: topical Route: multiple Dose: 3 %, 1 times / 2 hours Sources: |
healthy, ADULT Health Status: healthy Age Group: ADULT Sex: unknown Food Status: UNKNOWN Sources: |
|
20 g/m2 4 times / day multiple, topical Studied dose Dose: 20 g/m2, 4 times / day Route: topical Route: multiple Dose: 20 g/m2, 4 times / day Sources: |
healthy, ADULT Health Status: healthy Age Group: ADULT Sex: M+F Food Status: UNKNOWN Sources: |
PubMed
Title | Date | PubMed |
---|---|---|
Determination of UV-filters in sunscreens by HPLC. | 2001 Apr |
|
Comments on "In vitro and in vivo estrogenicity of UV screens". | 2001 Aug |
|
Determination of sixteen UV filters in suncare formulations by high-performance liquid chromatography. | 2004 Sep 17 |
|
Screening of 397 chemicals and development of a quantitative structure--activity relationship model for androgen receptor antagonism. | 2008 Apr |
|
Non-porous membrane-assisted liquid-liquid extraction of UV filter compounds from water samples. | 2009 Jun 12 |
Patents
Sample Use Guides
In Vivo Use Guide
Curator's Comment: 30 min after application the remaining product was removed from the skin with two dry cotton swabs and the skin was tape-stripped 16 times with D-Squames. The total amount of UV filters penetrating into the stratum corneum (strips 2–16) from the emulsion gel formulation was 25.7+/-6.4 ug/cm2 (23.2 % applied dose). The total amount of UV filters penetrating from the petroleum formulation was 8.3+/-3.6 ug/cm2 (9.0 % applied dose).
2 mg/cm2 Homosalate was applied to area (2x2 cm) on the volar side of the forearm.
Route of Administration:
Other
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/12566826
Human full-thickness skin was mounted in a conventional static Franz diffusion cells with a receptor volume of 12.4 ml. The UV filters were readily soluble in the receptor fluid. Epidermis and dermis separated by the hot plate method
(60°C for 2 min) and punch biopsies (8 mm) from the tissue samples were taken. Homosalate did not permeate through the skin after 6 h application.
Name | Type | Language | ||
---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 352.10
Created by
admin on Wed Apr 02 07:44:53 GMT 2025 , Edited by admin on Wed Apr 02 07:44:53 GMT 2025
|
||
|
CFR |
21 CFR 352.20
Created by
admin on Wed Apr 02 07:44:53 GMT 2025 , Edited by admin on Wed Apr 02 07:44:53 GMT 2025
|
||
|
EPA PESTICIDE CODE |
76603
Created by
admin on Wed Apr 02 07:44:53 GMT 2025 , Edited by admin on Wed Apr 02 07:44:53 GMT 2025
|
||
|
NCI_THESAURUS |
C851
Created by
admin on Wed Apr 02 07:44:53 GMT 2025 , Edited by admin on Wed Apr 02 07:44:53 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
3183
Created by
admin on Wed Apr 02 07:44:53 GMT 2025 , Edited by admin on Wed Apr 02 07:44:53 GMT 2025
|
PRIMARY | |||
|
C060446
Created by
admin on Wed Apr 02 07:44:53 GMT 2025 , Edited by admin on Wed Apr 02 07:44:53 GMT 2025
|
PRIMARY | |||
|
C83760
Created by
admin on Wed Apr 02 07:44:53 GMT 2025 , Edited by admin on Wed Apr 02 07:44:53 GMT 2025
|
PRIMARY | |||
|
204-260-8
Created by
admin on Wed Apr 02 07:44:53 GMT 2025 , Edited by admin on Wed Apr 02 07:44:53 GMT 2025
|
PRIMARY | |||
|
DTXSID1026241
Created by
admin on Wed Apr 02 07:44:53 GMT 2025 , Edited by admin on Wed Apr 02 07:44:53 GMT 2025
|
PRIMARY | |||
|
CHEMBL1377575
Created by
admin on Wed Apr 02 07:44:53 GMT 2025 , Edited by admin on Wed Apr 02 07:44:53 GMT 2025
|
PRIMARY | |||
|
91326
Created by
admin on Wed Apr 02 07:44:53 GMT 2025 , Edited by admin on Wed Apr 02 07:44:53 GMT 2025
|
PRIMARY | RxNorm | ||
|
1311408
Created by
admin on Wed Apr 02 07:44:53 GMT 2025 , Edited by admin on Wed Apr 02 07:44:53 GMT 2025
|
PRIMARY | |||
|
V06SV4M95S
Created by
admin on Wed Apr 02 07:44:53 GMT 2025 , Edited by admin on Wed Apr 02 07:44:53 GMT 2025
|
PRIMARY | |||
|
164918
Created by
admin on Wed Apr 02 07:44:53 GMT 2025 , Edited by admin on Wed Apr 02 07:44:53 GMT 2025
|
PRIMARY | |||
|
DB11064
Created by
admin on Wed Apr 02 07:44:53 GMT 2025 , Edited by admin on Wed Apr 02 07:44:53 GMT 2025
|
PRIMARY | |||
|
HOMOSALATE
Created by
admin on Wed Apr 02 07:44:53 GMT 2025 , Edited by admin on Wed Apr 02 07:44:53 GMT 2025
|
PRIMARY | |||
|
KK-99
Created by
admin on Wed Apr 02 07:44:53 GMT 2025 , Edited by admin on Wed Apr 02 07:44:53 GMT 2025
|
PRIMARY | |||
|
SUB08053MIG
Created by
admin on Wed Apr 02 07:44:53 GMT 2025 , Edited by admin on Wed Apr 02 07:44:53 GMT 2025
|
PRIMARY | |||
|
8362
Created by
admin on Wed Apr 02 07:44:53 GMT 2025 , Edited by admin on Wed Apr 02 07:44:53 GMT 2025
|
PRIMARY | |||
|
100000083986
Created by
admin on Wed Apr 02 07:44:53 GMT 2025 , Edited by admin on Wed Apr 02 07:44:53 GMT 2025
|
PRIMARY | |||
|
118-56-9
Created by
admin on Wed Apr 02 07:44:53 GMT 2025 , Edited by admin on Wed Apr 02 07:44:53 GMT 2025
|
PRIMARY | |||
|
m6047
Created by
admin on Wed Apr 02 07:44:53 GMT 2025 , Edited by admin on Wed Apr 02 07:44:53 GMT 2025
|
PRIMARY | Merck Index | ||
|
3279
Created by
admin on Wed Apr 02 07:44:53 GMT 2025 , Edited by admin on Wed Apr 02 07:44:53 GMT 2025
|
PRIMARY | |||
|
V06SV4M95S
Created by
admin on Wed Apr 02 07:44:53 GMT 2025 , Edited by admin on Wed Apr 02 07:44:53 GMT 2025
|
PRIMARY |
ACTIVE MOIETY